Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.6850 (1.92%) ($11.6850 - $11.7300) on Thu. Sep. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 46 | Latest Price | $11.6850(1.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.8% a day on average for past five trading days. | Weekly Trend | FOLD declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(57%) IWO(47%) IWC(46%) IWM(46%) IWN(45%) | Factors Impacting FOLD price | FOLD will decline at least -1.8% in a week (0% probabilities). VIXM(-18%) EDOC(-17%) UUP(-13%) VXX(-12%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.42(-62.17%) | Resistance Level | $11.8 | 5 Day Moving Average | $11.46(1.96%) | 10 Day Moving Average | $11.47(1.87%) | 20 Day Moving Average | $11.8(-0.97%) | To recent high | -8.6% | To recent low | 48.4% | Market Cap | $3.017b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |